HSBC Holdings’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,515,491
Closed -$15.2M 3151
2022
Q4
$15.2M Buy
1,515,491
+181,491
+14% +$1.8M 0.02% 753
2022
Q3
$13.1M Hold
1,334,000
0.02% 729
2022
Q2
$13M Hold
1,334,000
0.02% 760
2022
Q1
$13M Hold
1,334,000
0.02% 773
2021
Q4
$13M Buy
1,334,000
+207,636
+18% +$2.02M 0.01% 845
2021
Q3
$10.9M Buy
+1,126,364
New +$10.9M 0.01% 846

Other funds holding AONC

HSBC Holdings's AONC Position: Q1 2023 in Review

HSBC Holdings sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q1 2023, closing a stake of 1,515,491 shares — an estimated $15.2M sold.

HSBC Holdings first reported a position in AONC in Q3 2021 and held it in 6 quarters. The position peaked at $15.2M in Q4 2022. 13 funds tracked by Wall St. Rank hold AONC as of Q1 2023.

  • HSBC Holdings reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • HSBC Holdings sold 1,515,491 American Oncology Network, Inc. Class A Common Stock shares in Q1 2023, an estimated $15.2M.
  • HSBC Holdings first reported a position in American Oncology Network, Inc. Class A Common Stock in Q3 2021 and held it in 6 quarters.
  • HSBC Holdings's American Oncology Network, Inc. Class A Common Stock position peaked at $15.2M in Q4 2022.
  • 13 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q1 2023.

Based on HSBC Holdings's 13F filing for Q1 2023, filed 15 May 2023.